Clinical Trials

Showing trials with last updates posted in 2026.

NCT04887805 | ACTIVE_NOT_RECRUITING | PHASE2
28 participants

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-07-21
Completion:
2026-03-22
Conditions
  • Advanced Pancreatic Ductal Adenocarcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage IIA Pancreatic Cancer AJCC v8
  • Stage IIB Pancreatic Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Unresectable Pancreatic Ductal Adenocarcinoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04837716 | ACTIVE_NOT_RECRUITING | PHASE1
12 participants

Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-03-18
Completion:
2027-09-23
Conditions
  • Metastatic Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04556890 | RECRUITING | NA
54 participants

Pain and Major Depressive Disorder

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-03-01
Completion:
2027-12-31
Conditions
  • Major Depressive Disorder
  • Chronic Pain
Interventions
  • DEVICE
No Results Yet
NCT04526782 | ACTIVE_NOT_RECRUITING | PHASE2
119 participants

ENCOrafenib With Binimetinib in bRAF NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-01-19
Completion:
2025-07-16
Conditions
  • Non Small Cell Lung Cancer
  • BRAF V600E
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page